Universal Biosensors, Inc. (ASX:UBI)
Australia
· Delayed Price · Currency is AUD 0.0580
+0.0030 (5.45%)
Apr 30, 2025, 4:10 PM AEST
Universal Biosensors Revenue
In the year 2024, Universal Biosensors had annual revenue of 6.28M AUD, down -5.28%. Universal Biosensors had revenue of 1.32M in the quarter ending December 31, 2024, a decrease of -37.65%.
Revenue
6.28M
Revenue Growth
-5.28%
P/S Ratio
2.75
Revenue / Employee
82.67K
Employees
76
Market Cap
17.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.28M | -350.10K | -5.28% |
| Dec 31, 2023 | 6.63M | 2.11M | 46.58% |
| Dec 31, 2022 | 4.52M | -1.25M | -21.68% |
| Dec 31, 2021 | 5.78M | 2.58M | 80.41% |
| Dec 31, 2020 | 3.20M | -3.69M | -53.57% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |